Ignite Creation Date:
2025-12-25 @ 3:10 AM
Ignite Modification Date:
2026-02-12 @ 7:22 AM
Study NCT ID:
NCT02116205
Status:
COMPLETED
Last Update Posted:
2021-02-12
First Post:
2014-04-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 2a Immunogenicity Study of Hantaan/Puumala Virus DNA Vaccine for Prevention of Hemorrhagic Fever
Sponsor:
U.S. Army Medical Research and Development Command
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-07-09
Start Date Type:
ACTUAL
Primary Completion Date:
2016-12-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-07
Completion Date Type:
ACTUAL
First Submit Date:
2014-04-14
First Submit QC Date:
None
Study First Post Date:
2014-04-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-10-14
Results First Submit QC Date:
None
Results First Post Date:
2020-12-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-02-10
Last Update Post Date:
2021-02-12
Last Update Post Date Type:
ACTUAL